- Report
- August 2025
- 121 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- August 2025
- 188 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- October 2025
- 189 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 183 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- November 2025
- 280 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 107 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- February 2025
- 200 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- May 2025
- 110 Pages
Global
From €4238EUR$4,750USD£3,737GBP
- Report
- August 2025
- 182 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- July 2025
- 150 Pages
Global
From €5309EUR$5,950USD£4,681GBP
- Report
- January 2025
- 53 Pages
Global
From €6692EUR$7,500USD£5,901GBP
- Report
- July 2025
- 150 Pages
United States
From €5309EUR$5,950USD£4,681GBP
- Report
- November 2023
- 98 Pages
Global
From €3569EUR$4,000USD£3,147GBP
- Report
- July 2024
- 100 Pages
Global
From €2677EUR$3,000USD£2,360GBP
€3346EUR$3,750USD£2,950GBP
- Report
- February 2024
- 117 Pages
Europe
From €4238EUR$4,750USD£3,737GBP
- Report
- August 2024
- 222 Pages
North America
From €5349EUR$5,995USD£4,717GBP
- Report
- August 2024
- 270 Pages
Europe
From €5349EUR$5,995USD£4,717GBP
- Report
- August 2024
- 273 Pages
Asia Pacific
From €5349EUR$5,995USD£4,717GBP
- Report
- June 2024
- 72 Pages
Canada
From €4457EUR$4,995USD£3,930GBP

Renal Denervation is a minimally invasive procedure used to treat hypertension, or high blood pressure, by targeting the nerves that control the kidneys. It is a type of cardiovascular device that works by blocking the signals that cause the kidneys to produce hormones that increase blood pressure. The procedure is performed using a catheter that is inserted into the femoral artery and guided to the renal artery. Once in place, the catheter delivers radiofrequency energy to the renal nerves, which disrupts the signals that cause the kidneys to produce hormones that increase blood pressure.
Renal Denervation is a relatively new procedure, but it has been gaining traction in recent years as an effective treatment for hypertension. It is a safe and minimally invasive procedure that can be performed in an outpatient setting, and it has been shown to reduce blood pressure in patients with resistant hypertension.
Some companies in the Renal Denervation market include Medtronic, Abbott, Boston Scientific, and ReCor Medical. Show Less Read more